Gregory J. Bullington

Co-Founder & CEO

Greg Bullington is co-founder and CEO of Magnolia Medical Technologies. He has led all commercial aspects of company development since inception including clinical trial design and execution, peer-reviewed publication, product development, manufacturing, commercial launch and overall intellectual property strategy. To date, Greg has raised $25M in capital to drive the successful growth and development of the company.

Greg has extensive experience in the healthcare industry having led product commercialization and strategy engagements for a wide variety of companies in the biotech (novel immunotherapy), healthcare insurance, wellness and enterprise software sectors.

Greg began his career in professional services with the Audit & Assurance practice of Deloitte & Touche LLP. He continued his professional development as a management consultant with Lake Partners, a Seattle-based strategy firm. In 2006, Greg founded Forum Ventures, a technology commercialization consultancy focused on accelerating the growth of early and mid-stage technology companies.

Over the past 15 years, Greg has led engagements and worked with senior executive teams at over 50 companies ranging from Fortune 100 corporations to venture-backed and early stage startups as a consultant, advisor, and investor. Additionally, Greg has significant intellectual property expertise and is the first named inventor on 28 issued patents as well as over 50 pending US and international patent applications.

Richard G. Patton, M.D.

Co-Founder & Medical Director

Dr. Patton is a board-certified pathologist with more than 40 years of active practice experience. Recognizing the patient safety and financial implications of false positive blood cultures, he has long been interested in exploring opportunities to reduce contamination rates.

In 2006, Dr. Patton designed a clinical trial to test the effectiveness of Initial Specimen Diversion Technique (ISDT), an innovation that he conceived earlier in his career. The results of the trial were significantly positive and published in the peer-reviewed Journal of Clinical Microbiology.

Dr. Patton’s areas of expertise are clinical microbiology, gastrointestinal pathology, and cytopathology. He was the Chief of Pathology and Medical Director of Clinical Laboratories at Northwest Hospital, Seattle, Washington for four decades. He has served as a Laboratory Inspector, Washington State Commissioner, NW Regional Commissioner, and Accreditation and Complaints Committee Member for the College of American Pathologists Laboratory Accreditation Program.

Ward Sparacio

Vice President, Sales & Clinical Operations

Ward brings over 20 years of sales and company leadership experience within the technology and software sectors of healthcare and enterprise solutions.

Ward has held CEO and senior executive positions, managing domestic and international operations. He thrives on building and leading multi-functional teams that drive disruptive solutions and innovation into new markets. As a strategist and tactician, Ward has designed and executed numerous sales, marketing, and business development initiatives.

He spent his early career working with larger organizations such as Picker, ATL Ultrasound, and Philips Medical—all focused on sales and alternate channels. For the past 15 years, with new ventures like SonoSite, Confirma, and Carrot Medical, he led successful sales and marketing initiatives in coordination with designing and executing operations, finance, and capital strategies.

In entrepreneurial pursuits outside of medical technology, he has practiced in the media/entertainment industry, packaging, and financing independent films.

Jay Schwartz

Vice President, Strategy & Business Development

Jay brings a broad range of strategy and hands-on experience to Magnolia Medical Technologies in his role to help set the strategic and operating direction of the company while also supporting the overall business development effort. Initially working with the company since 2015 as an advisor, Jay joined Magnolia full time in the middle of 2016.

Prior to Magnolia Medical, Jay’s healthcare experience includes leading Sales, Account Management, Strategic Partner and Corporate Development efforts for a leading healthcare information technology and content company. In addition, he worked with many healthcare clients across the payer, provider, technology and device segments in his nearly 15 years of consulting experience.

His career includes a mix of professional services and operating leadership positions including consulting work with Bain, McKinsey and Lake Partners as well as operating roles with Procter & Gamble, PACCAR, Cintas and Milliman Care Guidelines. Jay has a Finance degree from Notre Dame and an MBA from Stanford.